Nebula Research & Development’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
53,571
+10,473
| +24% | +$226K | 0.1% | 350 |
|
|
2025
Q1 | $716K | Sell |
43,098
-6,939
| -14% | -$115K | 0.07% | 488 |
|
|
2024
Q4 | $918K | Buy |
50,037
+13,841
| +38% | +$254K | 0.11% | 322 |
|
|
2024
Q3 | $557K | Sell |
36,196
-64,082
| -64% | -$986K | 0.07% | 512 |
|
|
2024
Q2 | $1.63M | Buy |
100,278
+85,805
| +593% | +$1.39M | 0.26% | 101 |
|
|
2024
Q1 | $268K | Buy |
+14,473
| New | +$268K | 0.06% | 572 |
|